Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03536013 · ClinicalTrials.gov registry record · NA
Efficacy of a Full-Thickness Placental Allograft in Lumbar Microdiscectomy
A NA study, sponsored by StimLabs.
- Terminated
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT03536013 is a NA study that was terminated before completion, run by StimLabs. The registered enrollment target is 27 participants.
The verdict
NCT03536013, a NA study, was terminated before completion, sponsored by StimLabs.
- TERMINATED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
To evaluate the efficacy of full thickness placental allograft use in Microdiscectomy application. To evaluate post-microdiscectomy reherniation rate in patients treated with full-thickness placental allografts.
Interventions
- OTHER Other: Full-thickness placental allograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-05-03 |
| Est. Completion | 2019-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03536013
The ClinicalTrials.gov registry entry for NCT03536013 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is StimLabs, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Other: Full-thickness placental allograft is the first listed.
NCT03536013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03536013 about?
NCT03536013 is a clinical study titled "Efficacy of a Full-Thickness Placental Allograft in Lumbar Microdiscectomy". To evaluate the efficacy of full thickness placental allograft use in Microdiscectomy application. To evaluate post-microdiscectomy reherniation rate in patients treated with full-thickness placental allografts.
What is the current status of trial NCT03536013?
This trial is currently terminated. It is a NA study. The enrollment target is 27 participants. The study started on 2018-05-03. Estimated completion is 2019-08-01.
What interventions are being tested in trial NCT03536013?
The interventions under investigation include: Other: Full-thickness placental allograft (OTHER).
Who is sponsoring clinical trial NCT03536013?
This trial is sponsored by StimLabs, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.